Home › NDC Lookup › RxCUI directory › RxCUI 197892

Lithium carbonate 450 MG Extended Release Oral Tablet — RxCUI 197892

RxNorm drug concept · Semantic clinical drug
RxCUI 197892 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197892
Official nameLithium carbonate 450 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asLiCO3 450 MG Extended Release Oral Tablet
FDA products mapped10
Package NDCs mapped13
Reported Medicaid activity (SDUD)212,343 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lithium Carbonate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, lithium isn't a sedative. It's a mood stabilizer, which means it helps keep your mood more even over time. It specifically targets mania — the high, energized, and sometimes da...
  • What exactly does lithium do — is it like a sedative?
  • This is one of the most important things to understand about lithium: the amount that helps you and the amount that can seriously harm you are very close together. You can feel fin...
  • Why do I need blood tests so often? Can't my doctor just judge by how I feel?
📖 Read our full Lithium Carbonate guide →

🕸️ Concept Web — How Lithium carbonate 450 MG Extended Release Oral T... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lithium carbonate 450 MG Extended Release Oral Tablet RxCUI 197892

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lithium carbonate 42351
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lithium carbonate Extended Release Oral Tablet 372618
    • Lithium carbonate Oral Product 1164698
    • Lithium carbonate Pill 1164699
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Lithium carbonate 450 MG 332536

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lithium carbonate 450 MG SCDC · 332536
  • Lithium carbonate Extended Release Oral Tablet SCDF · 372618
  • Lithium carbonate Oral Product SCDG · 1164698
  • Lithium carbonate Pill SCDG · 1164699

📦 FDA Products & Package NDCs

10 products · 13 package NDCs
13 package NDCs map to RxCUI 197892 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0020-25 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0054-0020... Lithium Carbonate Hikma Pharmaceuticals USA Inc. 2004-01-13
42291-0496-01 100 TABLET in 1 BOTTLE (42291-496-01) Lithium Carbonate ER AvKARE 2022-02-25
43063-0901-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-901... Lithium Carbonate PD-Rx Pharmaceuticals, Inc. 2018-09-25
43063-0901-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-901-... Lithium Carbonate PD-Rx Pharmaceuticals, Inc. 2023-07-28
64980-0278-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-278-01) Lithium Carbonate Rising Pharma Holdings, Inc. 2018-03-01
67046-0408-03 30 TABLET in 1 BLISTER PACK (67046-0408-3) Lithium Carbonate ER Coupler LLC 2026-05-13
68084-0655-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-655-01) / 1 TAB... Lithium Carbonate American Health Packaging 2014-01-03
68462-0224-01 100 TABLET in 1 BOTTLE (68462-224-01) Lithium Carbonate ER Glenmark Pharmaceuticals Inc., USA 2011-02-14
68462-0224-10 1000 TABLET in 1 BOTTLE (68462-224-10) Lithium Carbonate ER Glenmark Pharmaceuticals Inc., USA 2011-02-14
68462-0224-30 30 TABLET in 1 BOTTLE (68462-224-30) Lithium Carbonate ER Glenmark Pharmaceuticals Inc., USA 2011-02-14
70518-2086-00 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2086-0) Lithium Carbonate REMEDYREPACK INC. 2019-05-16
70518-4589-00 30 TABLET in 1 BLISTER PACK (70518-4589-0) Lithium Carbonate ER REMEDYREPACK INC. 2026-03-20
70518-4678-00 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4678-0) Lithium Carbonate REMEDYREPACK INC. 2026-06-19
Observed labelers: Glenmark Pharmaceuticals Inc., USA (3) · REMEDYREPACK INC. (3) · PD-Rx Pharmaceuticals, Inc. (2) · American Health Packaging (1) · AvKARE (1) · Coupler LLC (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.